Skip to nav Skip to content

Basal Cell Carcinoma diagram showing layers of skin starting with epidermus

Basal cell carcinoma (BCC) is the most common form of skin cancer in the United States, accounting for roughly 3.6 million new diagnoses each year. The cancer begins in the basal cells, which sit at the base of the skin's outer layer (the epidermis) and produce new skin cells to replace old ones. Unlike more aggressive skin cancers, BCC tends to grow very slowly and rarely spreads (metastasizes) to other parts of the body.

 

Quick Facts: Basal Cell Carcinoma

  • Epidemiological Context: Outnumbers squamous cell carcinoma (1.8 million annual cases) and melanoma, representing the single most common cancer diagnosis nationwide
  • Primary Presentation Subtypes
    • Nodular BCC: The most common subtype, presenting typically as a distinct, shiny, or pearly round bump
    • Superficial BCC: Appears as a flat, scaly plaque with well-defined outer edges
    • Pigmented BCC: A rare variant containing dark melanin pigments that can closely mimic the appearance of a melanoma or standard mole
    • Invasive (Sclerosing) BCC: An aggressive, complex variant that initially mimics smooth, pale scar tissue or taut skin
  • Common Visual Lesion Warning Signs
    • A shiny pink, red, white, or clear nodule (may present as dark brown or black on darker skin tones)
    • An open sore that bleeds, oozes, or crusts and persistently fails to heal over several weeks
    • A pink growth characterized by rolled outer borders and an indented, central depression
    • An irregular, flat red patch that may trigger focal itching, crusting, or pain
  • Primary Risk Factors
    • Phenotypic Characteristics: High baseline susceptibility exists for individuals with fair skin, freckles, light eyes (blue or green), or naturally blonde or red hair
    • Environmental & Lifestyle Triggers: Elevated risk correlates with cumulative ultraviolet (UV) radiation exposure and a personal history of severe, blistering sunburns
    • Demographic & Biological Factors: Risk naturally increases with advanced age and a prolonged history of cell replication
    • Chemical & Radiation Exposure: Prolonged exposure to therapeutic radiation or environmental toxins, such as arsenic, coal tar, and paraffin, significantly elevates risk levels
  • Clinical Prognosis: Carries an excellent overall therapeutic outcome when identified early, yielding an 85% to 95% recurrence-free cure rate primarily through local surgical excision or specialized dermatological intervention

Basal Cell Carcinoma vs. Other Skin Cancers

While basal cell carcinoma is the most common form of skin cancer, it is frequently confused with other types of the disease. Understanding how it compares to other skin malignancies can help clear up confusion about your diagnosis, risk level, and treatment options.

Basal Cell Carcinoma vs. Squamous Cell Carcinoma  

Basal cell and squamous cell carcinomas are the two most common forms of skin cancer. Together with Merkel cell carcinoma, they fall under the umbrella term "nonmelanoma skin cancer."

While both are highly treatable, they look different and behave differently. Squamous cell carcinoma develops in the flat, scale-like cells on the very surface of the skin (the epidermis). While it is still considered low-risk, it is slightly more likely to spread to other areas of the body than basal cell carcinoma.

Basal cell carcinoma vs. melanoma  

Melanoma is the most dangerous and aggressive form of skin cancer. The crucial difference between basal cell carcinoma nad melanom lies in how they spread - while basal cell carcinoma almost always stays localized, melanoma can rapidly travel to distant organs and become life-threatening if it isn't caught early.

Melanoma also starts in a completely different cell type, the pigment-producing melanocytes, and typically shows up as a brand-new skin growth or an existing mole that is changing in size, shape, or color.

Sunscreen, sunglasses on beach to prevent sun damage

Basal cell carcinoma causes and prevention

Most experts agree that long-term exposure to ultraviolet (UV) radiation from sunlight is responsible for basal cell carcinoma, which is why the best way to prevent this skin cancer is to limit your time in the sun and regularly apply a broad-spectrum sunscreen of SPF 15 or higher when you’re outside—even on cloudy days. Here are a few other steps you can take:

  • Wear protective clothing, sunglasses and a broad-brimmed hat when outside.
  • Stay in the shade, or schedule outdoor activities in the early morning (before 10 a.m.) and evening (after 4 p.m.).   
  • Avoid using tanning beds and sunlamps.

It’s also recommended to see a dermatologist annually for a professional skin exam and routinely perform self-checks for changes in your skin, particularly on your face, scalp and other areas of your body that are often left uncovered.

Some people are more susceptible to sun damage than others and have greater risk of basal cell carcinoma. For example, individuals who have fair skin, freckles, blue or green eyes or red or blonde hair are considered more likely to develop skin cancer. Other risk factors for basal cell carcinoma include:

  • Being older
  • Being male
  • Having a history of burns or inflammatory skin diseases
  • Exposure to radiation and substances like arsenic, coal tar and paraffin
  • Person

    3.6 million cases

    of basal cell carcinoma are diagnosed each year in the U.S.

What are the symptoms of basal cell carcinoma? 

Basal cell carcinoma typically occurs on areas of the body that are frequently exposed to the sun, such as the face, scalp, ears, neck, back and shoulders, although it can develop anywhere on the body. Common signs and symptoms of basal cell carcinoma include:

  • A shiny bump that may appear pink, red, white or clear (in darker skin tones, the bump may be black or brown and look like a mole)
  • An open sore that may ooze, crust or bleed and does not heal after several weeks
  • A pink growth with rolled edges and a central depression 
  • A red patch of skin that may itch, crust or cause pain
  • A taut, shiny area of white or yellow skin with irregular borders that may resemble scar tissue  
  • An unusual pigmented growth

Not all skin abnormalities indicate cancer. Only a physician can diagnose or rule out basal cell carcinoma, so it’s important to promptly consult with a medical professional if any changes in skin occur.

Basal cell carcinoma types  

There are multiple types of basal cell carcinoma, including:

  • Nodular basal cell skin cancer – The most common subtype, this cancer typically presents as a round, shiny bump.
  • Superficial basal cell skin cancer – This subtype may appear as a scaley plaque with defined borders.
  • Pigmented basal cell skin cancer – A very rare nonmelanoma skin cancer that may resemble melanoma.
  • Invasive (sclerosing) basal cell skin cancer – An uncommon and complex cancer that can appear as pale scar tissue in its initial stages.

Basal cell carcinoma survival rate and prognosis

Skin excision for basal cell carcinomaThe overall prognosis for basal cell carcinoma is excellent, especially when it is diagnosed in an early stage. Today’s treatment approaches for this skin cancer offer an 85% to 95% recurrence-free cure rate. In rare cases, basal cell carcinoma can be disfiguring or life-threatening if it is left untreated.

Squamous cell and basal cell carcinoma deaths are not officially reported, but it’s estimated that roughly 2,000 people die of these nonmelanoma skin cancers every year in the U.S., with squamous cell cancer comprising the majority of deaths. Skin cancers are more dangerous in older populations and people with compromised immune systems.  

Diagnosing basal cell carcinoma

To confirm a diagnosis of basal cell carcinoma, a physician will perform a biopsy and send the sample to a pathologist for further evaluation in a lab. One of several biopsies may be recommended depending on the size and shape of the skin lesion:

  • A shave biopsy – Top layers of the skin are gently scraped off with a sharp blade.
  • A punch biopsy – A small, round instrument is used to “punch” and remove a deeper section of the skin.
  • An excisional biopsy – Surgical techniques are used to remove the entire lesion, along with a small margin of surrounding healthy skin.

Moffitt Cancer Center’s approach to basal cell carcinoma treatment

At Moffitt Cancer Center, we take an innovative, multispecialty approach to treating basal cell carcinoma. In our Cutaneous Oncology Program, an experienced team of oncologists (all of whom focus exclusively on the treatment of skin cancer) will review each patient’s case to determine which therapies would be most suitable. After considering the cellular makeup of the cancer, the patient’s ability to tolerate certain treatments and a number of other unique factors, our tumor board may recommend:

  • Surgery – Most basal cell carcinomas can be surgically managed through a traditional excision, but our experienced skin cancer surgeons can also perform more complex operations (e.g. a lymph node resection or a graft reconstruction) in cases of advanced basal cell carcinoma.
  • Radiation therapy – Moffitt’s radiation oncologists can formulate a treatment plan that delivers the maximum safe dose of ionizing radiation to a cancerous lesion, while minimizing exposure to nearby healthy skin.
  • Immunotherapy – These therapies target various molecules in the body (such as the protein interleukin-2) to induce an immune response to the basal cell carcinoma.
  • Chemotherapy – Topical chemotherapy can be used to treat precancerous lesions, while systemic chemotherapy drugs may be administered to address basal cell carcinomas that have reached the lymphatic system and spread to distant organs. 

Several other treatments, such as adoptive cell therapy and intralesional therapy, are also available through our robust clinical trial program. As a National Cancer Institute-designated Comprehensive Cancer Center, we are at the forefront of groundbreaking research that benefits not only our patients but every individual who has been diagnosed with basal cell carcinoma. Plus, these trials allow us to provide our patients with access to the widest possible range of therapies in one convenient location.

To learn more about basal cell carcinoma treatment at Moffitt Cancer Center, call 1-888-663-3488 or complete a new patient registration form. As Florida’s top cancer hospital, we’re expanding access to world-class care by connecting patients with cancer experts rapidly.